CXDO.NASDAQCrexendo, INC

Form 4: Crexendo COO Executes Stock Option Exercises and Sales

Sentiment:

Statement of Changes in Beneficial Ownership


Crexendo Chief Operating Officer Douglas Walter Gaylor exercised options and sold 80,000 shares of common stock.

Summary

  • Douglas Walter Gaylor, Chief Operating Officer of Crexendo, Inc., exercised stock options for 75,000 shares at an exercise price of $6.26.
  • Following the exercises, Gaylor sold a total of 80,000 shares of common stock between May 29, 2026, and June 2, 2026.
  • The sales were executed at prices ranging from $9.9901 to $10.35 per share.
  • The reporting person's direct beneficial ownership in Crexendo, Inc. stands at 222,816 shares following these transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents standard executive equity management rather than a strategic shift or operational update.

Positives

  • The executive maintains a significant remaining equity stake of 222,816 shares in the company.

Negatives

  • The transaction represents a reduction in the executive's direct holdings through the sale of 80,000 shares.

Risks

  • Insider selling can sometimes be perceived by the market as a lack of confidence in future share price appreciation, though these are often routine liquidity events.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that executive stock sales are common occurrences for liquidity or tax planning purposes and do not necessarily reflect a change in the company's fundamental business trajectory.

Comparison to Industry Standards

  • The exercise and sale of vested stock options is a standard component of executive compensation packages in the technology and telecommunications sectors.

Stakeholder Impact

  • Shareholders should note the change in insider ownership levels, though the remaining stake remains substantial.

Next Steps

  • No future actions or milestones were disclosed in this filing.

Key Dates

DateDescription
05/29/2026Date of initial option exercise and share sale.
06/01/2026Date of secondary option exercise and share sale.
06/02/2026Date of final share sale and filing signature.

Keywords

Crexendo, CXDO, Insider Trading, Form 4, Stock Options, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.